Lamees Hegazy, Ph.D., assistant professor of medicinal chemistry at University of Health Sciences and Pharmacy in St. Louis, was the recent recipient of a three-year, $581,000 grant from the National Institutes of Health’s (NIH) National Institute of Diabetes and Digestive and Kidney Diseases.
Hegazy will utilize the grant funding to further her research efforts to target the estrogen-related receptor alpha (ERRα) with the goal of identifying novel antidiabetic agents.
With the Centers for Disease Control and Prevention currently estimating that nearly 37.3 million people in America have diabetes, the chronic health condition is the leading cause of death in the U.S., and it currently has no cure.